Novogen Research Pty Ltd.
Records under this name other than patents Novogen Research Pty Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Novogen Research Pty Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,080,675 | Chroman derivatives, medicaments and use in therapy Formerly held In force · USPTO record | In force | USPTO record | |
| US RE40,792 | Health supplements containing phyto-oestrogens, analogues or metabolites thereof Term ended Term ended Jun 23, 2026 · USPTO record | Term ended | Term ended Jun 23, 2026 | USPTO record |
| US 7,601,855 | Substituted chroman derivatives, medicaments and use in therapy Formerly held Term ended Ended no later than Sep 21, 2025 · USPTO record | Term ended | Ended no later than Sep 21, 2025 | USPTO record |
| US 8,084,628 | Substituted chroman derivatives, medicaments and use in therapy Formerly held Term ended Term ended Sep 21, 2025 · USPTO record | Term ended | Term ended Sep 21, 2025 | USPTO record |
| US 8,163,795 | Chroman derivatives, medicaments and use in therapy Formerly held Lapsed on the fee record Ended Apr 24, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 24, 2024 | USPTO record |
| US 8,461,361 | Chroman derivatives, medicaments and use in therapy Formerly held Lapsed on the fee record Ended Jun 11, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 11, 2021 | USPTO record |
| US 9,381,186 | Substituted chroman derivatives, medicaments and use in therapy Formerly held Lapsed on the fee record Ended Jul 5, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 5, 2020 | USPTO record |
| US 6,455,032 | Composition and method for protecting skin from UV induced immunosuppression and skin damage Formerly held Term ended Term ended Jun 23, 2020 · USPTO record | Term ended | Term ended Jun 23, 2020 | USPTO record |
| US 9,198,895 | Chroman derivatives, medicaments and use in therapy Formerly held Lapsed on the fee record Ended Dec 1, 2019 · USPTO record | Lapsed on the fee record | Ended Dec 1, 2019 | USPTO record |
| US 9,138,478 | Substituted chroman derivatives, medicaments and use in therapy Formerly held Lapsed on the fee record Ended Sep 22, 2019 · USPTO record | Lapsed on the fee record | Ended Sep 22, 2019 | USPTO record |